Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 18 Issue 2, February 2022

COVER: Inspired by the Review on p67.

Cover design: Alex Whitworth

Research Highlights

  • Advertisement

  • The results of a phase IIb study suggest that ianalumab, an anti-BAFF receptor antibody, could have disease-modifying effects in primary Sjögren syndrome.

    • Joanna Clarke
    Research Highlight
  • Results of a case–control study suggest that delayed hypersensitivity reactions to IL-1 or IL-6 inhibitors are strongly associated with a common HLA class II haplotype.

    • Sarah Onuora
    Research Highlight
  • In a multicentre, longitudinal study, researchers have evaluated the association of baseline criteria in patients with Raynaud phenomenon and 5-year progression to systemic sclerosis.

    • Robert Phillips
    Research Highlight
  • Results from the iFAME-Fertility study indicate that pre-conception paternal inflammatory arthritis is associated with the subsequent risk of miscarriage.

    • Robert Phillips
    Research Highlight
  • Oral tofacitinib led to fewer flares in patients with juvenile idiopathic arthritis than placebo, according to the results of a phase III trial.

    • Joanna Clarke
    Research Highlight
Top of page ⤴

News & Views

  • New research reports that men with inflammatory arthritis experience an impact on sexual health beyond erectile dysfunction, affecting their emotional, mental, and social health. Training to empower health professionals to have conversations about sex could improve support for people with rheumatic diseases.

    • Caroline A. Flurey
    News & Views
Top of page ⤴

Reviews

Top of page ⤴

Search

Quick links